Sarepta Therapeutics, Inc. (SRPT)
USD 49.3
(-5.92%)
USD 49.3
(-5.92%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.24 Billion USD | 33.26% |
| 2022 | 933.01 Million USD | 32.93% |
| 2021 | 701.88 Million USD | 29.96% |
| 2020 | 540.09 Million USD | 41.82% |
| 2019 | 380.83 Million USD | 26.51% |
| 2018 | 301.03 Million USD | 94.74% |
| 2017 | 154.58 Million USD | 2751.58% |
| 2016 | 5.42 Million USD | 332.64% |
| 2015 | 1.25 Million USD | -87.16% |
| 2014 | 9.75 Million USD | -31.38% |
| 2013 | 14.21 Million USD | -61.91% |
| 2012 | 37.32 Million USD | -20.56% |
| 2011 | 46.99 Million USD | 59.72% |
| 2010 | 29.42 Million USD | 67.3% |
| 2009 | 17.58 Million USD | -17.28% |
| 2008 | 21.25 Million USD | 93.52% |
| 2007 | 10.98 Million USD | 9428.23% |
| 2006 | 115.29 Thousand USD | -97.59% |
| 2005 | 4.78 Million USD | 1011.31% |
| 2004 | 430.46 Thousand USD | -55.62% |
| 2003 | 969.86 Thousand USD | 15.9% |
| 2002 | 836.78 Thousand USD | 18.51% |
| 2001 | 706.1 Thousand USD | -45.57% |
| 2000 | 1.29 Million USD | 1197.34% |
| 1999 | 100 Thousand USD | -50.0% |
| 1998 | 200 Thousand USD | 100.0% |
| 1997 | 100 Thousand USD | 0.0% |
| 1996 | 100 Thousand USD | 0.0% |
| 1995 | 100 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 413.46 Million USD | 4.2% |
| 2024 Q2 | 362.93 Million USD | -12.22% |
| 2023 Q2 | 261.23 Million USD | 3.05% |
| 2023 FY | 1.24 Billion USD | 33.26% |
| 2023 Q4 | 396.78 Million USD | 19.58% |
| 2023 Q1 | 253.5 Million USD | -1.91% |
| 2023 Q3 | 331.81 Million USD | 27.02% |
| 2022 FY | 933.01 Million USD | 32.93% |
| 2022 Q4 | 258.42 Million USD | 12.23% |
| 2022 Q3 | 230.26 Million USD | -1.38% |
| 2022 Q1 | 210.83 Million USD | 4.65% |
| 2022 Q2 | 233.48 Million USD | 10.75% |
| 2021 FY | 701.88 Million USD | 29.96% |
| 2021 Q1 | 146.93 Million USD | 1.24% |
| 2021 Q2 | 164.08 Million USD | 11.68% |
| 2021 Q3 | 189.4 Million USD | 15.43% |
| 2021 Q4 | 201.46 Million USD | 6.36% |
| 2020 Q3 | 143.92 Million USD | 4.78% |
| 2020 Q2 | 137.36 Million USD | 20.84% |
| 2020 FY | 540.09 Million USD | 41.82% |
| 2020 Q1 | 113.67 Million USD | 13.55% |
| 2020 Q4 | 145.13 Million USD | 0.84% |
| 2019 Q4 | 100.11 Million USD | 1.08% |
| 2019 Q2 | 94.66 Million USD | 8.8% |
| 2019 Q3 | 99.04 Million USD | 4.62% |
| 2019 Q1 | 87.01 Million USD | 3.08% |
| 2019 FY | 380.83 Million USD | 26.51% |
| 2018 Q2 | 73.52 Million USD | 13.81% |
| 2018 FY | 301.03 Million USD | 94.74% |
| 2018 Q4 | 84.41 Million USD | 7.55% |
| 2018 Q3 | 78.48 Million USD | 6.74% |
| 2018 Q1 | 64.6 Million USD | 12.79% |
| 2017 Q4 | 57.27 Million USD | 24.64% |
| 2017 FY | 154.58 Million USD | 2751.58% |
| 2017 Q1 | 16.34 Million USD | 201.46% |
| 2017 Q2 | 35.01 Million USD | 114.24% |
| 2017 Q3 | 45.95 Million USD | 31.26% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | 5.42 Million USD | 332.64% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q4 | 5.42 Million USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | 1.25 Million USD | -87.16% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | 1.25 Million USD | 0.0% |
| 2014 FY | 9.75 Million USD | -31.38% |
| 2014 Q2 | 2.58 Million USD | -57.57% |
| 2014 Q1 | 6.08 Million USD | 131.84% |
| 2014 Q3 | 1.05 Million USD | -59.0% |
| 2014 Q4 | 27 Thousand USD | -97.45% |
| 2013 Q2 | 2.95 Million USD | -34.04% |
| 2013 Q1 | 4.47 Million USD | -39.01% |
| 2013 Q3 | 4.16 Million USD | 41.24% |
| 2013 Q4 | 2.62 Million USD | -37.0% |
| 2013 FY | 14.21 Million USD | -61.91% |
| 2012 Q3 | 7.57 Million USD | -32.42% |
| 2012 FY | 37.32 Million USD | -20.56% |
| 2012 Q2 | 11.2 Million USD | -0.04% |
| 2012 Q1 | 11.21 Million USD | -17.47% |
| 2012 Q4 | 7.33 Million USD | -3.14% |
| 2011 Q2 | 11.58 Million USD | -18.96% |
| 2011 FY | 46.99 Million USD | 59.72% |
| 2011 Q3 | 7.52 Million USD | -35.05% |
| 2011 Q4 | 13.58 Million USD | 80.56% |
| 2011 Q1 | 14.29 Million USD | -7.87% |
| 2010 Q3 | 8.7 Million USD | 117.71% |
| 2010 Q2 | 3.99 Million USD | 231.7% |
| 2010 Q1 | 1.2 Million USD | -76.56% |
| 2010 Q4 | 15.51 Million USD | 78.32% |
| 2010 FY | 29.42 Million USD | 67.3% |
| 2009 Q3 | 6.34 Million USD | 115.59% |
| 2009 FY | 17.58 Million USD | -17.28% |
| 2009 Q1 | 3.15 Million USD | -42.52% |
| 2009 Q2 | 2.94 Million USD | -6.51% |
| 2009 Q4 | 5.14 Million USD | -19.03% |
| 2008 Q4 | 5.47 Million USD | 5.98% |
| 2008 FY | 21.25 Million USD | 93.52% |
| 2008 Q2 | 4.98 Million USD | -11.41% |
| 2008 Q1 | 5.62 Million USD | 8.45% |
| 2008 Q3 | 5.17 Million USD | 3.77% |
| 2007 Q3 | 2.91 Million USD | 23.81% |
| 2007 Q1 | 536.04 Thousand USD | 2959.78% |
| 2007 FY | 10.98 Million USD | 9428.23% |
| 2007 Q4 | 5.18 Million USD | 78.14% |
| 2007 Q2 | 2.35 Million USD | 338.66% |
| 2006 Q3 | 13.25 Thousand USD | -28.59% |
| 2006 Q2 | 18.55 Thousand USD | -71.87% |
| 2006 Q1 | 65.96 Thousand USD | -95.35% |
| 2006 FY | 115.29 Thousand USD | -97.59% |
| 2006 Q4 | 17.51 Thousand USD | 32.2% |
| 2005 Q1 | 45.19 Thousand USD | -84.18% |
| 2005 Q4 | 1.41 Million USD | -56.81% |
| 2005 Q3 | 3.28 Million USD | 8247.04% |
| 2005 Q2 | 39.31 Thousand USD | -13.0% |
| 2005 FY | 4.78 Million USD | 1011.31% |
| 2004 Q1 | 99.45 Thousand USD | -26.43% |
| 2004 Q3 | 9151.00 USD | -74.77% |
| 2004 Q4 | 285.58 Thousand USD | 3020.84% |
| 2004 Q2 | 36.27 Thousand USD | -63.53% |
| 2004 FY | 430.46 Thousand USD | -55.62% |
| 2003 Q3 | 414.35 Thousand USD | 155.13% |
| 2003 Q2 | 162.41 Thousand USD | -37.03% |
| 2003 Q1 | 257.92 Thousand USD | 52.43% |
| 2003 FY | 969.86 Thousand USD | 15.9% |
| 2003 Q4 | 135.18 Thousand USD | -67.38% |
| 2002 Q4 | 169.2 Thousand USD | -27.13% |
| 2002 Q1 | 237.69 Thousand USD | -19.51% |
| 2002 Q2 | 197.69 Thousand USD | -16.83% |
| 2002 Q3 | 232.19 Thousand USD | 17.45% |
| 2002 FY | 836.78 Thousand USD | 18.51% |
| 2001 Q3 | 307.54 Thousand USD | 252.44% |
| 2001 Q1 | 15.98 Thousand USD | -36.08% |
| 2001 Q2 | 87.26 Thousand USD | 446.08% |
| 2001 Q4 | 295.3 Thousand USD | -3.98% |
| 2001 FY | 706.1 Thousand USD | -45.57% |
| 2000 FY | 1.29 Million USD | 1197.34% |
| 2000 Q2 | 18.25 Thousand USD | -98.39% |
| 2000 Q1 | 1.13 Million USD | 0.0% |
| 2000 Q3 | 122.21 Thousand USD | 569.67% |
| 2000 Q4 | 25 Thousand USD | -79.54% |
| 1999 Q4 | - USD | -100.0% |
| 1999 FY | 100 Thousand USD | -50.0% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 FY | 200 Thousand USD | 100.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | 900.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1997 FY | 100 Thousand USD | 0.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q3 | 20 Thousand USD | 0.0% |
| 1996 FY | 100 Thousand USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q4 | 10 Thousand USD | -50.0% |
| 1996 Q2 | - USD | 0.0% |
| 1995 FY | 100 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 194.62 Million USD | -538.843% |
| Jaguar Health, Inc. | 9.76 Million USD | -12637.793% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -823301.325% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 31.995% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -846.842% |
| ContextLogic Inc. | 287 Million USD | -333.218% |
| MiMedx Group, Inc. | 321.47 Million USD | -286.757% |
| MEI Pharma, Inc. | 65.29 Million USD | -1804.124% |
| AlloVir, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 983.7 Million USD | -26.393% |
| Aptorum Group Limited | 431.37 Thousand USD | -288124.249% |
| Ardelyx, Inc. | 124.45 Million USD | -899.017% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -416.475% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -19873.269% |
| Pharming Group N.V. | 245.31 Million USD | -406.83% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -182207.331% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -2804.312% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -963.753% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -12905.607% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 26.97 Million USD | -4509.045% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -605.511% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -79908.752% |
| Acelyrin, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -48448.848% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -14061.002% |
| AbCellera Biologics Inc. | 38.02 Million USD | -3169.786% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -24866620.0% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -89996.812% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -863.729% |
| Chimerix, Inc. | 324 Thousand USD | -383645.679% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -116754.887% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.66 Billion USD | 25.254% |
| Fortress Biotech, Inc. | 84.51 Million USD | -1371.177% |
| Fortress Biotech, Inc. | 84.51 Million USD | -1371.177% |
| Agenus Inc. | 156.31 Million USD | -695.409% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -6076.839% |
| Dyadic International, Inc. | 2.89 Million USD | -42791.315% |
| ImmuCell Corporation | 17.47 Million USD | -7016.298% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -3829.385% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -5216.81% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 66.357% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -15282.111% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -477188.292% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -12413.446% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -154929.426% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -1878.606% |
| NextCure, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -6427.041% |
| Onconetix, Inc. | 58.46 Thousand USD | -2126533.028% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -158286.752% |
| Opthea Limited | 261.85 Thousand USD | -474711.253% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -37237.417% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Seer, Inc. | 15.18 Million USD | -8089.54% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -15014.709% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -293139.623% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -997.336% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -658.529% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -5890.249% |
| ChromaDex Corporation | 83.57 Million USD | -1387.778% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -10222.424% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -3506.277% |
| CRISPR Therapeutics AG | 371.2 Million USD | -234.945% |
| Precision BioSciences, Inc. | 48.72 Million USD | -2451.637% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -1856.992% |
| Innoviva, Inc. | 310.46 Million USD | -300.478% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -24164.949% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -5005.264% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -12433260.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -68974.222% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -212.236% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -44948.406% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -148029.227% |
| Century Therapeutics, Inc. | 2.23 Million USD | -55530.246% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -5806.865% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -1128.423% |
| Autolus Therapeutics plc | 1.69 Million USD | -73123.557% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -2601.847% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -1828335.294% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -630.189% |
| GRI Bio, Inc. | 21.76 Million USD | -5612.023% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -48850.506% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -58272.582% |
| INmune Bio, Inc. | 155 Thousand USD | -802052.258% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -878.666% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -55431.085% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -124233.6% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -14402.928% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -383.329% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -35423.886% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -78592.152% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -15905.87% |
| Histogen Inc. | 3.76 Million USD | -32888.485% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -213080.712% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -1140575.229% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -317324.527% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -3569.931% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -18042.945% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -688.179% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -852668.176% |
| Apollomics, Inc. | 821 Thousand USD | -151341.657% |
| Amarin Corporation plc | 306.91 Million USD | -305.113% |
| Mesoblast Limited | 5.9 Million USD | -20966.35% |
| Turnstone Biologics Corp. | 19.3 Million USD | -6340.153% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -1482.013% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -608.401% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 32.066% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -1514.995% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -213.506% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -93313.674% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -788.662% |
| Insmed Incorporated | 305.2 Million USD | -307.373% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -6553.837% |
| OmniAb, Inc. | 34.16 Million USD | -3539.316% |
| Alector, Inc. | 97.06 Million USD | -1180.971% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -884.236% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -1207022.33% |
| Zai Lab Limited | 266.71 Million USD | -366.16% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -431.249% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -956312.308% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -7026.36% |
| Veracyte, Inc. | 361.05 Million USD | -244.366% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -26942.388% |
| FibroGen, Inc. | 147.75 Million USD | -741.502% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -841100.23% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 67.573% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -295932.381% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -226.518% |
| TG Therapeutics, Inc. | 233.66 Million USD | -432.109% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 60.008% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -79703.338% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -3540.275% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -1365.87% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -2065.185% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -186.319% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -2678.032% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -275.163% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -2253136.68% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -4681.326% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -13814744.444% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -37450.168% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 90.521% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -1018093.134% |
| Pluri Inc. | 326 Thousand USD | -381291.411% |
| Prothena Corporation plc | 91.37 Million USD | -1260.77% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -1962.567% |
| Celularity Inc. | 22.77 Million USD | -5360.173% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -22547.286% |
| MeiraGTx Holdings plc | 14.01 Million USD | -8770.2% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -398.475% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -1845.601% |
| Blueprint Medicines Corporation | 249.38 Million USD | -398.571% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -3912.185% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -16936.668% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -3327.529% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -24788.358% |
| Cytokinetics, Incorporated | 7.53 Million USD | -16411.766% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -59523.443% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -896.303% |
| Evogene Ltd. | 5.64 Million USD | -21944.965% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -12342.069% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -13264.893% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -25802.833% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -3303.882% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -395866.879% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -62066.8% |
| MediciNova, Inc. | 1 Million USD | -124233.6% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -50710.625% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -7285783.387% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -359.474% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -32.577% |
| Mereo BioPharma Group plc | 10 Million USD | -12333.36% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -21644.246% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -5899.788% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -360.054% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -44225.704% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -157.753% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -1308674.737% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -26031.484% |
| Kezar Life Sciences, Inc. | 7 Million USD | -17661.943% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -5829.683% |
| aTyr Pharma, Inc. | 353 Thousand USD | -352119.83% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -7906.543% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -395866.879% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -10310340.335% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -49.934% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -549542.807% |
| UroGen Pharma Ltd. | 82.71 Million USD | -1403.193% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -708.774% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -4496594.394% |
| Orgenesis Inc. | 530 Thousand USD | -234491.698% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -638.595% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -490226.651% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -545.419% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -549542.807% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -7285783.387% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -82623.619% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -23788.464% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -11245.342% |
| scPharmaceuticals Inc. | 13.59 Million USD | -9046.884% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -12304.829% |
| Daré Bioscience, Inc. | 2.8 Million USD | -44180.161% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -675626.087% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 49.433% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -10636.926% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -1972.227% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -4115.127% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 48.606% |
| DBV Technologies S.A. | 15.72 Million USD | -7805.239% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 81.844% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -15430.052% |
| Molecular Templates, Inc. | 57.3 Million USD | -2069.644% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -756.068% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -12223.679% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -17963.867% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -2016.353% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -192612.686% |
| Adagene Inc. | 18.11 Million USD | -6764.901% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -114810.906% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -330.302% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -397.318% |
| SciSparc Ltd. | 2.87 Million USD | -43086.384% |
| Vericel Corporation | 197.51 Million USD | -529.486% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -20959.214% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -1985.924% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -4767.048% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -1185.301% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -1138.543% |
| ADMA Biologics, Inc. | 258.21 Million USD | -381.512% |
| Clene Inc. | 654 Thousand USD | -190012.538% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -4838.171% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -2689.312% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -2386.672% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -1161896.262% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -1342.72% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1700490.874% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -2027.434% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -10474.383% |
| Trevena, Inc. | 3.12 Million USD | -39686.752% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -71.155% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -19673.155% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -15686.389% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -199793.248% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -22747.042% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -1672.573% |
| Celularity Inc. | 22.77 Million USD | -5360.173% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -30882.706% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -794775.303% |
| Cibus, Inc. | 1.81 Million USD | -68327.958% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -34437.111% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -17257.755% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -64522.453% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -57.854% |
| Eyenovia, Inc. | 3787.00 USD | -32831587.351% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -427.649% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -1027.037% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -254681.967% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1469.789% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -137277.755% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -524514.346% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -18268.09% |
| Royalty Pharma plc | 2.35 Billion USD | 47.194% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -169321.601% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -3273.588% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -731274.118% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -103167.11% |
| Notable Labs, Ltd. | 310 Thousand USD | -400976.129% |
| Liquidia Corporation | 17.48 Million USD | -7009.652% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -114810.906% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -6753.735% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -66674.221% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -72499.535% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 46.581% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -1724312.638% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -26031.484% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -4144353.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -7747.857% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -1821.605% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -291762.911% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -211.335% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -3615.999% |
| Peak Bio, Inc. | 367.87 Thousand USD | -337876.008% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -4427.643% |
| Benitec Biopharma Inc. | 216 Thousand USD | -575518.519% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -140231.377% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -1.388% |
| Immunome, Inc. | 14.01 Million USD | -8769.568% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -74935.365% |
| CervoMed Inc. | 7.14 Million USD | -17301.795% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -25207.063% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -43896.32% |
| Moolec Science SA | 905.04 Thousand USD | -137277.755% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -149337.627% |
| AnaptysBio, Inc. | 17.15 Million USD | -7146.815% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -50441.107% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -56338.311% |
| Lumos Pharma, Inc. | 2.05 Million USD | -60520.965% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -2952.99% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -59523.443% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -609378.431% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -1036013.333% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -497234.4% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -229.178% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -567.119% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -3008.34% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -104469.891% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -7946.961% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -218029.123% |
| HCW Biologics Inc. | 2.84 Million USD | -43651.799% |
| XOMA Corporation | 4.75 Million USD | -26031.484% |
| Nektar Therapeutics | 90.12 Million USD | -1279.614% |
| Arvinas, Inc. | 78.5 Million USD | -1483.868% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -2729.172% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -40085.391% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -190012.538% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -70907.196% |
| Synlogic, Inc. | 3.37 Million USD | -36783.299% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -337876.008% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -6134.448% |
| Krystal Biotech, Inc. | 50.69 Million USD | -2352.388% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -751.408% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -22726.069% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -276432.249% |
| MannKind Corporation | 198.96 Million USD | -524.911% |
| Ikena Oncology, Inc. | 9.16 Million USD | -13473.537% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -995.933% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -336.039% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -31083300.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -2378.987% |
| REGENXBIO Inc. | 90.24 Million USD | -1277.78% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -55641.979% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -16749.654% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -164580.265% |
| Longeveron Inc. | 709 Thousand USD | -175264.739% |
| Repare Therapeutics Inc. | 51.13 Million USD | -2331.573% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -10636.926% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -591964.762% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 87.402% |
| Denali Therapeutics Inc. | 330.53 Million USD | -276.163% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -7529.252% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -45898.372% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -1505.796% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -815576.704% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -8233.91% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -184097.926% |
| OmniAb, Inc. | 34.16 Million USD | -3539.316% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -5750.442% |
| Lipocine Inc. | -2.85 Million USD | 43713.307% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -55431.085% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -1406.873% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -1338.131% |
| Ocugen, Inc. | 6.03 Million USD | -20498.675% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -107455.017% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -3345.671% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -20614.651% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -196287.944% |
| Dominari Holdings Inc. | 2.03 Million USD | -60877.734% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -7.271% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -4535.335% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -113.624% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -9771.663% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -260557.442% |
| Iterum Therapeutics plc | - USD | -Infinity% |